Permixon Side Effects

8322019-0 | International Normalised Ratio Increased, Hypothrombinaemia, International Normalised Ratio Decreased
on Apr 17, 2012 Male patient from FRANCE , 86 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), pseudomembranous colitis and was treated with Permixon(View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased, hypothrombinaemia, international normalised ratio decreased. Permixon dosage: . During the same period patient was treated with ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), PREVISCAN /00789001/ (PREVISCAN FLUIDIONE) (NOT SPECIFIED) (20 Mg Qd Oral) (View Previscan /00789001/ (previscan - Fluidione) (not Specified) Review and Previscan /00789001/ (previscan - Fluidione) (not Specified) Label ), FLAGYL (500 Mg Tid Oral) (View Flagyl Review and Flagyl Label ), LAMICTAL (View Lamictal Review and Lamictal Label ). Patient was hospitalized.

8169088-9 | Hyperkalaemia
Patient was taking Permixon (View Usage). Patient had the following side effects: hyperkalaemia on Feb 21, 2012 from FRANCE Additional patient health information: Male patient , weighting 253.5 lb, was diagnosed with benign prostatic hyperplasia, prophylaxis, insomnia, hyperuricaemia, back pain (What is back pain?), type 2 diabetes mellitus, renal failure chronic, hypertension and. Permixon dosage: 160 Mg. During the same period patient was treated with ASPIRIN (75 Mg) (View Aspirin Review and Aspirin Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), ADENURIC (80 Mg) (View Adenuric Review and Adenuric Label ), MOBIC (15 Mg/1.5 Ml) (View Mobic Review and Mobic Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LASIX (125 Mg) (View Lasix Review and Lasix Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

8112782-6 | Atrial Fibrillation, Subdural Haematoma
Adverse event was reported on Jan 24, 2012 by a Male patient taking Permixon (View Usage) (Dosage: Caps) . Location: FRANCE , 89 years of age, After Permixon was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), subdural haematoma. During the same period patient was treated with TAMSULOSIN HCL (Extended Release Microgranules In Capsule) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ZOLPIDEM (1df: 1 Tab Of 10mg) (View Zolpidem Review and Zolpidem Label ), PRIMIDONE (View Primidone Review and Primidone Label ), LASIX (1df: 1 Tab Of 40mg) (View Lasix Review and Lasix Label ), MEMANTINE HYDROCHLORIDE (1df: 1 Tab Of 10 Mg, Film-coated Tablet) (View Memantine Hydrochloride Review and Memantine Hydrochloride Label ), EXELON (Caps) (View Exelon Review and Exelon Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ARIXTRA (Strength:7.5 Mg/0.6 Ml.injection In Pre-filled Syringe) (View Arixtra Review and Arixtra Label ). Patient was hospitalized.

8038002-9 | Hepatitis
on Jan 09, 2012 Male patient from FRANCE , 62 years of age, was diagnosed with prostatic adenoma, type 2 diabetes mellitus, hypercholesterolaemia and was treated with Permixon (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Permixon dosage: Unk. During the same period patient was treated with GLICLAZIDE (Unk) (View Gliclazide Review and Gliclazide Label ), KETOPROFEN (Unk) (View Ketoprofen Review and Ketoprofen Label ), EFFEXOR (Unk) (View Effexor Review and Effexor Label ), FLUDARA (10, Unk) (View Fludara Review and Fludara Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (Unk) (View Tramadol Hydrochloride And Acetaminophen Review and Tramadol Hydrochloride And Acetaminophen Label ), LYRICA (Unk) (View Lyrica Review and Lyrica Label ), COTRIM (Unk) (View Cotrim Review and Cotrim Label ). Patient was hospitalized.


8008573-7 | Gastroenteritis Viral, Decreased Appetite, Weight Decreased, Abdominal Pain, Dehydration, Vomiting
on Dec 06, 2011 Male patient from FRANCE , 63 years of age, was diagnosed with hypertension and was treated with Permixon (serenoa Repens Extract)(View Usage). Patient had the following side effects: gastroenteritis viral, decreased appetite, weight decreased, abdominal pain (What is abdominal pain?), dehydration, vomiting. Permixon (serenoa Repens Extract) dosage: . During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL (Oral) (View Amlodipine Besylate And Olmesartan Medoxomil Review and Amlodipine Besylate And Olmesartan Medoxomil Label ). Patient was hospitalized.

7732358-X | Erythema, Altered State Of Consciousness, Hypercalcaemia, Rash Maculo-papular
Patient was taking Permixon (View Usage). After Permixon was administered, patient had the following side effects: erythema, altered state of consciousness, hypercalcaemia, rash maculo-papular on Aug 30, 2011 from FRANCE Additional patient health information: Male patient , 71 years of age, . Permixon dosage: 160 Mg, Unk. During the same period patient was treated with BISOPROLOL FUMARATE (2.5 Mg, Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), OXYCODONE HCL (5 Mg, Unk) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ATORVASTATIN CALCIUM (40 Mg, Unk) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PANTOPRAZOLE (20 Mg, Unk) (View Pantoprazole Review and Pantoprazole Label ), OXYCONTIN (20 Mg, Unk) (View Oxycontin Review and Oxycontin Label ), PROSCAR (5 Mg, Unk) (View Proscar Review and Proscar Label ), ARIXTRA (Unk) (View Arixtra Review and Arixtra Label ), ASPIRIN (160 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7709731-9 | Hypotension, Headache, Tremor, Vertigo
Adverse event was reported on Aug 10, 2011 by a Male patient taking Permixon (lipidosterolic Extract Of Serenoa Repens) (View Usage) (Dosage: 2 Df (1 Dosage Forms, 2 In 1 D), Oral) was diagnosed with prostatic adenoma, arteriosclerosis, hypertension and. Location: FRANCE , 90 years of age, Patient experienced the following unwanted or unexpected effects: hypotension, headache (What is headache?), tremor, vertigo. During the same period patient was treated with ISKEDYL FORT (DIHYDROERGOCRISTINE MESILATE, RAUBASINE) (TABLETS) (2 Df (1 Dosage Forms, 2 In 1 D), Oral) (View Iskedyl Fort (dihydroergocristine Mesilate, Raubasine) (tablets) Review and Iskedyl Fort (dihydroergocristine Mesilate, Raubasine) (tablets) Label ), TENSTATEN (CICLETANINE HYDROCHLORIDE) (50 Mg, Oral) (View Tenstaten (cicletanine Hydrochloride) Review and Tenstaten (cicletanine Hydrochloride) Label ), MILNACIPRAN (MILNACIPRAN HYDROCHLORIDE) (CAPSULES) (100 Mg (50 Mg, 2 In 1 D), Oral) (View Milnacipran (milnacipran Hydrochloride) (capsules) Review and Milnacipran (milnacipran Hydrochloride) (capsules) Label ). Patient was hospitalized.

7437077-5 | Gastrointestinal Haemorrhage
on Apr 14, 2011 Male patient from SINGAPORE , weighting 181.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Permixon (View Usage). Patient had the following side effects: gastrointestinal haemorrhage. Permixon dosage: 2 Df, Every 6 Hrs. During the same period patient was treated with SIMVASTATIN (20 Mg, Each Evening) (View Simvastatin Review and Simvastatin Label ), NECITUMUMAB (11F8) (LY3012211) (800 Mg, Other) (View Necitumumab (11f8) (ly3012211) Review and Necitumumab (11f8) (ly3012211) Label ), CISPLATIN (148 Mg, Other) (View Cisplatin Review and Cisplatin Label ), VENTOLIN HFA (2 Df, Every 6 Hrs) (View Ventolin Hfa Review and Ventolin Hfa Label ), GEMCITABINE HYDROCHLORIDE (1871 Mg, Other) (View Gemcitabine Hydrochloride Review and Gemcitabine Hydrochloride Label ), PLAVIX (75 Mg, Unk) (View Plavix Review and Plavix Label ), BISOPROLOL (5 Mg, Unk) (View Bisoprolol Review and Bisoprolol Label ), PROCODIN (10 Ml, Tid) (View Procodin Review and Procodin Label ). Patient was hospitalized.

7233304-8 | Suicidal Ideation, Staphylococcal Infection, Delusion, Dysphagia, Neuroleptic Malignant Syndrome, Depression
on Jan 14, 2011 Male patient from FRANCE , weighting 149.9 lb, was treated with Permixon(View Usage). After Permixon was administered, patient had the following side effects: suicidal ideation, staphylococcal infection (What is staphylococcal infection?), delusion, dysphagia, neuroleptic malignant syndrome, depression (What is depression?). Permixon dosage: . During the same period patient was treated with RIBAVIRIN (Frequency: Daily, Permanently Discontnued.) (View Ribavirin Review and Ribavirin Label ), LYSANXIA (View Lysanxia Review and Lysanxia Label ), XATRAL (Tdd: 1) (View Xatral Review and Xatral Label ), MOVICOL (Tdd: 1) (View Movicol Review and Movicol Label ), PEGINTERFERON ALFA 2A (Permanently Discontinued.) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), HALDOL (50 Mg/month) (View Haldol Review and Haldol Label ), HYDROSOL POLYVITAMINE (View Hydrosol Polyvitamine Review and Hydrosol Polyvitamine Label ), LEPTICUR (View Lepticur Review and Lepticur Label ). Patient was hospitalized.

4899043-3 | Dysaesthesia, Hypoaesthesia, Motor Dysfunction, Neuropathy Peripheral, Paraesthesia
Patient was taking Permixon (View Usage). Patient experienced the following unwanted or unexpected effects: dysaesthesia, hypoaesthesia, motor dysfunction, neuropathy peripheral, paraesthesia on Sep 20, 2005 from FRANCE Additional patient health information: Male patient , 80 years of age, . Permixon dosage: . During the same period patient was treated with KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), TAHOR (80 Mg, Qd) (View Tahor Review and Tahor Label ), TAREG (80 Mg, Qd) (View Tareg Review and Tareg Label ). Patient was hospitalized.

4779728-X | Neuropathy Peripheral
Adverse event was reported on Sep 20, 2005 by a Male patient taking Permixon (View Usage) (Dosage: ) . Location: FRANCE , 80 years of age, Patient had the following side effects: neuropathy peripheral. During the same period patient was treated with KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), TAHOR (80 Mg, Qd) (View Tahor Review and Tahor Label ), TAREG (80 Mg, Qd) (View Tareg Review and Tareg Label ). Patient was hospitalized.

4556625-6 | Atelectasis, Condition Aggravated, Hypercapnic Encephalopathy, Pleural Effusion, Pleuropericarditis
on Nov 30, 2004 Male patient from , 79 years of age, weighting 196.2 lb, was diagnosed with micturition disorder, dyslipidaemia, essential hypertension, diabetes mellitus non-insulin-dependent, bronchitis chronic and was treated with Permixon (View Usage). After Permixon was administered, patient had the following side effects: atelectasis, condition aggravated, hypercapnic encephalopathy, pleural effusion, pleuropericarditis. Permixon dosage: 160 Mg/day. During the same period patient was treated with TAHOR (10 Mg, Qd) (View Tahor Review and Tahor Label ), NISISCO (1 Df, Qd) (View Nisisco Review and Nisisco Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), BECOTIDE (View Becotide Review and Becotide Label ). Patient was hospitalized.